rsos190366_si_002.xml (820.71 kB)
Supplementary Material from In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
Version 2 2020-10-15, 12:30
Version 1 2019-05-08, 10:10
dataset
posted on 2019-05-08, 10:10 authored by Hanwen Wang, Oleg Milberg, Imke H. Bartelink, Paolo Vicini, Bing Wang, Rajesh Narwal, Lorin Roskos, Cesar A. Santa-Maria, Aleksander S. PopelModel SBML code